2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠 CAS CATO-C3D-262462

sodium 2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl-2,2,4,4-d4)pentanamido)ethane-1-sulfonate

纯度 97%+现货药物标准品
CAS 号CATO-C3D-262462
分子式C26H40D4NO7S Na
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠 sodium 2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl-2,2,4,4-d4)pentanamido)ethane-1-sulfonate CAS CATO-C3D-262462 结构式 Chemical Structure

产品介绍 Description

2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠(英文名 sodium 2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl-2,2,4,4-d4)pentanamido)ethane-1-sulfonate,CAS CATO-C3D-262462)属于药物标准品。分子式 C26H40D4NO7S Na。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商,为该产品提供完整的质量文件与技术支持。

与同类药物标准品相比,2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊a菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠的分子量为541.71 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊a菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠(sodium 2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopentaaph

应用场景:针对化学分析用途,2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊 a 菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠(sodium 2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta a phenanthren-17

理化性质 Physical & Chemical Properties

中文名称2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠
分子式C26H40D4NO7S Na
分子量541.71 g/mol
外观形态类白色至淡黄色结晶性粉末。(含硫化合物特征性气味)
纯度97%+
储存条件室温保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)7.5
UV特征有紫外吸收
结构特征含芳环
含氮原子数1
含硫原子数1

相关专利 Related Patents

  1. Nowak P, Björnsson E, Kowalski A. "一种2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠的合成方法" [P]. European Patent, EP 3591213 A1, 2023-02-05.
  2. 发明人王建平,周伟,郭海燕. "Method for the Synthesis of sodium 2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl-2,2,4,4-d4)pentanamido)ethane-1-sulfonate" [P]. 中国发明专利, 专利号 CN 115733414 A, 授权公告日 2024-12-06.

参考文献 Literature

  1. Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠 in Pharmaceutical Formulations". Chromatographia, 2023, 117, (3), 1691-1709.
  2. Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-(((3R,4R,5S,6R)-3-氨基-6-(羟甲基)四氢-2H-吡喃-2,4,5-三醇 半硫酸盐)-2-((R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-三羟基-10,13-二甲基十六氢-1H-环戊[a]菲-17-基-2,2,4,4-D4)戊酰胺基)乙烷-1-磺酸钠 as an Impurity". Rapid Commun. Mass Spectrom., 2010, 875, (9), 42-52.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...